Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 72

1.

Association Between Birth Defects and Cancer Risk Among Children and Adolescents in a Population-Based Assessment of 10 Million Live Births.

Lupo PJ, Schraw JM, Desrosiers TA, Nembhard WN, Langlois PH, Canfield MA, Copeland G, Meyer RE, Brown AL, Chambers TM, Sok P, Danysh HE, Carozza SE, Sisoudiya SD, Hilsenbeck SG, Janitz AE, Oster ME, Scheuerle AE, Schiffman JD, Luo C, Mian A, Mueller BA, Huff CD, Rasmussen SA, Scheurer ME, Plon SE.

JAMA Oncol. 2019 Jun 20. doi: 10.1001/jamaoncol.2019.1215. [Epub ahead of print] Erratum in: JAMA Oncol. 2019 Aug 1;5(8):1232.

PMID:
31219523
2.

Weight trends in a multiethnic cohort of pediatric acute lymphoblastic leukemia survivors: A longitudinal analysis.

Foster KL, Kern KD, Chambers TM, Lupo PJ, Kamdar KY, Scheurer ME, Brown AL.

PLoS One. 2019 May 31;14(5):e0217932. doi: 10.1371/journal.pone.0217932. eCollection 2019.

3.

Perinatal and familial risk factors for soft tissue sarcomas in childhood through young adulthood: A population-based assessment in 4 million live births.

Lupo PJ, Luna-Gierke RE, Chambers TM, Tavelin B, Scheurer ME, Melin B, Papworth K.

Int J Cancer. 2019 Apr 13. doi: 10.1002/ijc.32335. [Epub ahead of print]

PMID:
30980537
4.

Hypospadias Risk from Maternal Residential Exposure to Heavy Metal Hazardous Air Pollutants.

White JT, Kovar E, Chambers TM, Sheth KR, Peckham-Gregory EC, O'Neill M, Langlois PH, Jorgez CJ, Lupo PJ, Seth A.

Int J Environ Res Public Health. 2019 Mar 15;16(6). pii: E930. doi: 10.3390/ijerph16060930.

5.
6.

Hypospadias risk is increased with maternal residential exposure to hormonally active hazardous air pollutants.

Sheth KR, Kovar E, White JT, Chambers TM, Peckham-Gregory EC, O'Neill M, Langlois PH, Seth A, Scheurer ME, Lupo PJ, Jorgez CJ.

Birth Defects Res. 2019 Apr 15;111(7):345-352. doi: 10.1002/bdr2.1461. Epub 2019 Jan 29.

PMID:
30694020
7.

Epidemiology of anophthalmia and microphthalmia: Prevalence and patterns in Texas, 1999-2009.

Chambers TM, Agopian AJ, Lewis RA, Langlois PH, Danysh HE, Weber KA, Shaw GM, Mitchell LE, Lupo PJ.

Am J Med Genet A. 2018 Sep;176(9):1810-1818. doi: 10.1002/ajmg.a.40352. Epub 2018 Aug 2.

PMID:
30070760
8.

Intermittent or uneven daily administration of low-dose hydroxyurea is effective in treating children with sickle cell anemia in Angola.

Chambers TM, Kahan S, Camanda JF, Scheurer M, Airewele GE.

Pediatr Blood Cancer. 2018 Dec;65(12):e27365. doi: 10.1002/pbc.27365. Epub 2018 Jul 26.

PMID:
30051651
9.

Humoral and cell-mediated immune responses to influenza vaccination in equine metabolic syndrome (EMS) horses.

Elzinga S, Reedy S, Barker VD, Chambers TM, Adams AA.

Vet Immunol Immunopathol. 2018 May;199:32-38. doi: 10.1016/j.vetimm.2018.03.009. Epub 2018 Mar 23.

PMID:
29678227
10.

Absence of relationship between type-I interferon suppression and neuropathogenicity of EHV-1.

Oladunni FS, Sarkar S, Reedy S, Balasuriya UBR, Horohov DW, Chambers TM.

Vet Immunol Immunopathol. 2018 Mar;197:24-30. doi: 10.1016/j.vetimm.2018.01.007.

PMID:
29475503
11.

Development of a novel equine influenza virus live-attenuated vaccine.

Rodriguez L, Reedy S, Nogales A, Murcia PR, Chambers TM, Martinez-Sobrido L.

Virology. 2018 Mar;516:76-85. doi: 10.1016/j.virol.2018.01.005. Epub 2018 Jan 11.

12.

Phylogenetic Analysis and Characterization of a Sporadic Isolate of Equine Influenza A H3N8 from an Unvaccinated Horse in 2015.

Sreenivasan CC, Jandhyala SS, Luo S, Hause BM, Thomas M, Knudsen DEB, Leslie-Steen P, Clement T, Reedy SE, Chambers TM, Christopher-Hennings J, Nelson E, Wang D, Kaushik RS, Li F.

Viruses. 2018 Jan 11;10(1). pii: E31. doi: 10.3390/v10010031.

13.

Equine herpesvirus-1 infection disrupts interferon regulatory factor-3 (IRF-3) signaling pathways in equine endothelial cells.

Sarkar S, Balasuriya UB, Horohov DW, Chambers TM.

Vet Immunol Immunopathol. 2016 May;173:1-9. doi: 10.1016/j.vetimm.2016.03.009. Epub 2016 Mar 14.

PMID:
27090619
14.

The neuropathogenic T953 strain of equine herpesvirus-1 inhibits type-I IFN mediated antiviral activity in equine endothelial cells.

Sarkar S, Balasuriya UB, Horohov DW, Chambers TM.

Vet Microbiol. 2016 Feb 1;183:110-8. doi: 10.1016/j.vetmic.2015.12.011. Epub 2015 Dec 19.

PMID:
26790943
15.

Equine herpesvirus-1 suppresses type-I interferon induction in equine endothelial cells.

Sarkar S, Balasuriya UB, Horohov DW, Chambers TM.

Vet Immunol Immunopathol. 2015 Oct 15;167(3-4):122-9. doi: 10.1016/j.vetimm.2015.07.015. Epub 2015 Aug 5.

PMID:
26275803
16.

Serological evidence of equine influenza infections among persons with horse exposure, Iowa.

Larson KR, Heil GL, Chambers TM, Capuano A, White SK, Gray GC.

J Clin Virol. 2015 Jun;67:78-83. doi: 10.1016/j.jcv.2015.04.009. Epub 2015 Apr 9.

PMID:
25959164
17.

Interaction between anthelmintic treatment and vaccine responses in ponies naturally infected with cyathostomins.

Nielsen MK, Rubinson EF, Chambers TM, Horohov DW, Wagner B, Betancourt A, Reedy SE, Jacobsen S.

Vet Immunol Immunopathol. 2015 Apr 15;164(3-4):110-7. doi: 10.1016/j.vetimm.2015.01.009. Epub 2015 Feb 7.

PMID:
25704666
18.

Characterization of the in situ immunological responses to vaccine adjuvants.

Horohov DW, Dunham J, Liu C, Betancourt A, Stewart JC, Page AE, Chambers TM.

Vet Immunol Immunopathol. 2015 Mar 15;164(1-2):24-9. doi: 10.1016/j.vetimm.2014.12.015. Epub 2015 Jan 8.

PMID:
25619587
19.

Rapid detection of equine influenza virus H3N8 subtype by insulated isothermal RT-PCR (iiRT-PCR) assay using the POCKIT™ Nucleic Acid Analyzer.

Balasuriya UB, Lee PY, Tiwari A, Skillman A, Nam B, Chambers TM, Tsai YL, Ma LJ, Yang PC, Chang HF, Wang HT.

J Virol Methods. 2014 Oct;207:66-72. doi: 10.1016/j.jviromet.2014.06.016. Epub 2014 Jun 30.

PMID:
24992669
20.

Equine influenza serological methods.

Chambers TM, Reedy SE.

Methods Mol Biol. 2014;1161:411-22. doi: 10.1007/978-1-4939-0758-8_36.

PMID:
24899450
21.

Equine influenza culture methods.

Chambers TM, Reedy SE.

Methods Mol Biol. 2014;1161:403-10. doi: 10.1007/978-1-4939-0758-8_35.

PMID:
24899449
22.

Equine influenza diagnosis: sample collection and transport.

Chambers TM, Reedy SE.

Methods Mol Biol. 2014;1161:371-7. doi: 10.1007/978-1-4939-0758-8_32.

PMID:
24899446
23.

A brief introduction to equine influenza and equine influenza viruses.

Chambers TM.

Methods Mol Biol. 2014;1161:365-70. doi: 10.1007/978-1-4939-0758-8_31. Review.

PMID:
24899445
24.

Development of a surveillance scheme for equine influenza in the UK and characterisation of viruses isolated in Europe, Dubai and the USA from 2010-2012.

Woodward AL, Rash AS, Blinman D, Bowman S, Chambers TM, Daly JM, Damiani A, Joseph S, Lewis N, McCauley JW, Medcalf L, Mumford J, Newton JR, Tiwari A, Bryant NA, Elton DM.

Vet Microbiol. 2014 Mar 14;169(3-4):113-27. doi: 10.1016/j.vetmic.2013.11.039. Epub 2013 Dec 21.

PMID:
24480583
25.

Replication of avian influenza viruses in equine tracheal epithelium but not in horses.

Chambers TM, Balasuriya UB, Reedy SE, Tiwari A.

Influenza Other Respir Viruses. 2013 Dec;7 Suppl 4:90-3. doi: 10.1111/irv.12188.

26.

Immunogenicity and clinical protection against equine influenza by DNA vaccination of ponies.

Ault A, Zajac AM, Kong WP, Gorres JP, Royals M, Wei CJ, Bao S, Yang ZY, Reedy SE, Sturgill TL, Page AE, Donofrio-Newman J, Adams AA, Balasuriya UB, Horohov DW, Chambers TM, Nabel GJ, Rao SS.

Vaccine. 2012 Jun 6;30(26):3965-74. doi: 10.1016/j.vaccine.2012.03.026. Epub 2012 Mar 23.

27.

Antigenic and genetic evolution of equine influenza A (H3N8) virus from 1968 to 2007.

Lewis NS, Daly JM, Russell CA, Horton DL, Skepner E, Bryant NA, Burke DF, Rash AS, Wood JL, Chambers TM, Fouchier RA, Mumford JA, Elton DM, Smith DJ.

J Virol. 2011 Dec;85(23):12742-9. doi: 10.1128/JVI.05319-11. Epub 2011 Sep 21.

28.

Diagnostic application of H3N8-specific equine influenza real-time reverse transcription polymerase chain reaction assays for the detection of Canine influenza virus in clinical specimens.

Lu Z, Dubovi EJ, Zylich NC, Crawford PC, Sells S, Go YY, Loynachan AT, Timoney PJ, Chambers TM, Balasuriya UB.

J Vet Diagn Invest. 2010 Nov;22(6):942-5.

PMID:
21088179
29.

Humoral and cell-mediated immune responses of old horses following recombinant canarypox virus vaccination and subsequent challenge infection.

Adams AA, Sturgill TL, Breathnach CC, Chambers TM, Siger L, Minke JM, Horohov DW.

Vet Immunol Immunopathol. 2011 Feb 15;139(2-4):128-40. doi: 10.1016/j.vetimm.2010.09.006. Epub 2010 Oct 7.

PMID:
21035197
30.

Infectivity of equine H3N8 influenza virus in bovine cells and calves.

Lin C, Holland RE Jr, McCoy MH, Donofrio-Newman J, Vickers ML, Chambers TM.

Influenza Other Respir Viruses. 2010 Nov;4(6):357-61.

31.

Isolation and characterisation of equine influenza viruses (H3N8) from Europe and North America from 2008 to 2009.

Bryant NA, Rash AS, Woodward AL, Medcalf E, Helwegen M, Wohlfender F, Cruz F, Herrmann C, Borchers K, Tiwari A, Chambers TM, Newton JR, Mumford JA, Elton DM.

Vet Microbiol. 2011 Jan 10;147(1-2):19-27. doi: 10.1016/j.vetmic.2010.05.040. Epub 2010 Jun 1.

PMID:
20580170
32.

A new strategy of immune evasion by influenza A virus: inhibition of monocyte differentiation into dendritic cells.

Boliar S, Chambers TM.

Vet Immunol Immunopathol. 2010 Aug 15;136(3-4):201-10. doi: 10.1016/j.vetimm.2010.03.004. Epub 2010 Mar 10.

PMID:
20356633
33.

Immunosenescence of the equine immune system.

Horohov DW, Adams AA, Chambers TM.

J Comp Pathol. 2010 Jan;142 Suppl 1:S78-84. doi: 10.1016/j.jcpa.2009.10.007. Epub 2009 Nov 7. Review.

PMID:
19897209
34.

Development and evaluation of one-step TaqMan real-time reverse transcription-PCR assays targeting nucleoprotein, matrix, and hemagglutinin genes of equine influenza virus.

Lu Z, Chambers TM, Boliar S, Branscum AJ, Sturgill TL, Timoney PJ, Reedy SE, Tudor LR, Dubovi EJ, Vickers ML, Sells S, Balasuriya UB.

J Clin Microbiol. 2009 Dec;47(12):3907-13. doi: 10.1128/JCM.00598-09. Epub 2009 Oct 21.

35.

Antigenic and genetic variations in European and North American equine influenza virus strains (H3N8) isolated from 2006 to 2007.

Bryant NA, Rash AS, Russell CA, Ross J, Cooke A, Bowman S, MacRae S, Lewis NS, Paillot R, Zanoni R, Meier H, Griffiths LA, Daly JM, Tiwari A, Chambers TM, Newton JR, Elton DM.

Vet Microbiol. 2009 Jul 2;138(1-2):41-52. doi: 10.1016/j.vetmic.2009.03.004. Epub 2009 Mar 13.

PMID:
19346084
36.

Influenza A viruses with truncated NS1 as modified live virus vaccines: pilot studies of safety and efficacy in horses.

Chambers TM, Quinlivan M, Sturgill T, Cullinane A, Horohov DW, Zamarin D, Arkins S, GarcĂ­a-Sastre A, Palese P.

Equine Vet J. 2009 Jan;41(1):87-92.

37.
38.

A new modified live equine influenza virus vaccine: phenotypic stability, restricted spread and efficacy against heterologous virus challenge.

Chambers TM, Holland RE, Tudor LR, Townsend HG, Cook A, Bogdan J, Lunn DP, Hussey S, Whitaker-Dowling P, Youngner JS, Sebring RW, Penner SJ, Stiegler GL.

Equine Vet J. 2001 Nov;33(7):630-6.

PMID:
11770982
39.

Cultures of equine respiratory epithelial cells and organ explants as tools for the study of equine influenza virus infection.

Lin C, Holland RE Jr, Williams NM, Chambers TM.

Arch Virol. 2001;146(11):2239-47.

PMID:
11765925
40.

Caspase activation in equine influenza virus induced apoptotic cell death.

Lin C, Holland RE Jr, Donofrio JC, McCoy MH, Tudor LR, Chambers TM.

Vet Microbiol. 2002 Feb 4;84(4):357-65. Review.

PMID:
11750143
41.

The involvement of a stress-activated pathway in equine influenza virus-mediated apoptosis.

Lin C, Zimmer SG, Lu Z, Holland RE Jr, Dong Q, Chambers TM.

Virology. 2001 Aug 15;287(1):202-13.

42.

Diverged evolution of recent equine-2 influenza (H3N8) viruses in the Western Hemisphere.

Lai AC, Chambers TM, Holland RE Jr, Morley PS, Haines DM, Townsend HG, Barrandeguy M.

Arch Virol. 2001;146(6):1063-74.

PMID:
11504416
43.

Derivation and characterization of a live attenuated equine influenza vaccine virus.

Youngner JS, Whitaker-Dowling P, Chambers TM, Rushlow KE, Sebring R.

Am J Vet Res. 2001 Aug;62(8):1290-4.

PMID:
11497453
44.

Safety, efficacy, and immunogenicity of a modified-live equine influenza virus vaccine in ponies after induction of exercise-induced immunosuppression.

Lunn DP, Hussey S, Sebing R, Rushlow KE, Radecki SV, Whitaker-Dowling P, Youngner JS, Chambers TM, Holland RE Jr, Horohov DW.

J Am Vet Med Assoc. 2001 Mar 15;218(6):900-6.

PMID:
11294315
45.

Sialic acid species as a determinant of the host range of influenza A viruses.

Suzuki Y, Ito T, Suzuki T, Holland RE Jr, Chambers TM, Kiso M, Ishida H, Kawaoka Y.

J Virol. 2000 Dec;74(24):11825-31.

46.
47.

Pharmacokinetics and therapeutic efficacy of rimantadine in horses experimentally infected with influenza virus A2.

Rees WA, Harkins JD, Lu M, Holland RE Jr, Lehner AF, Tobin T, Chambers TM.

Am J Vet Res. 1999 Jul;60(7):888-94.

PMID:
10407485
48.

Cloning and chromosomal localization of MX1 and ETS2 to chromosome 26 of the horse (Equus caballus)

Lear TL, Breen M, Ponce de Leon FA, Coogle L, Ferguson EM, Chambers TM, Bailey E.

Chromosome Res. 1998 Jun;6(4):333-5. No abstract available.

PMID:
9688525
49.

Amantadine and equine influenza: pharmacology, pharmacokinetics and neurological effects in the horse.

Rees WA, Harkins JD, Woods WE, Blouin RA, Lu M, Fenger C, Holland RE, Chambers TM, Tobin T.

Equine Vet J. 1997 Mar;29(2):104-10.

PMID:
9104558
50.

Antigenic and genetic evolution of equine H3N8 influenza A viruses.

Daly JM, Lai AC, Binns MM, Chambers TM, Barrandeguy M, Mumford JA.

J Gen Virol. 1996 Apr;77 ( Pt 4):661-71.

PMID:
8627254

Supplemental Content

Loading ...
Support Center